Oncology Therapeutics / NCI
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Oncology Therapeutics / NCI
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameOncology Therapeutics / NCI
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Ipilimumab
Generic: Ipilimumab
Class: Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)
Indications: Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Direct Communication & Assistance
Send an Inquiry to Oncology Therapeutics / NCI
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
